Biological coagulation findings in third-generation oral contraceptives.


An increased risk of venous thrombosis has been demonstrated in women receiving oral contraceptives (OCs). This risk has been primarily associated with the oestrogen content, but recent studies showed that the progestogen may also play a role. A higher risk was found with the so-called third-generation (desogestrel, gestodene) as compared with the second… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.